The Indian nutraceutical market is witnessing significant growth & hence nutraceutical companies will play a huge role in combating health issues.
Cipla, a Rs. 21,600 crore plus pharma major, reported single-digit revenue and profit growth in the third quarter ended December 2022. Its consolidated revenues increased by 6% to Rs. 5,810 crore, up from Rs. 5,479 crore in the same period last...
Sirnaomics Ltd., a leading biopharmaceutical firm in the research and development of RNAi therapies, reported that STP705 is moving forward in clinical trials for the treatment of two non-melanoma skin cancers:..
Ellipses Pharma (Ellipses), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, announced that the US Food and Drug Administration (FDA) has...
The overall performance of the Telangana Drug Manufacturers Association (TDMA), which is the state affiliate of the Indian Drug Manufacturers’ Association (IDMA), will be improved to strengthen the activities connected with the pharma MSME sector...
Finance Minister Nirmala Sitharaman announced on Wednesday a new programme to promote pharmaceutical research and innovation through various centres of excellence. "We will also encourage industry to invest in R&D," ...
Improving hospital architecture in India has the potential to significantly improve healthcare accessibility. According to Alpana Gupta, partner at Vijay Gupta Architects, extensive studies conducted by healthcare professionals and healthcare...
The domestic pharmaceutical market in India is projected to reach USD 130 billion by 2030, and the pharma sector has maintained its growing momentum after the pandemic. In FY21, the nation's pharmaceutical exports saw a strong growth of 24%,...
Alkem (Intenza, critical care division) announced the launch of its novel anti-infective in India under the brand name Zidavi. The newly launched antibiotic for multiple drug resistance (MDR) infections is in line with the company’s endeavour to...
Slovenian pharmaceutical firm Krka, d. d., Novo mesto is in discussions to acquire the promoter’s stake in Mumbai-based Unichem Laboratories, said two people aware of the development.